Micropulse Transscleral Cyclophotocoagulation (mTSCPC)

Nathan M. Radcliffe, Tarika Thareja

Research output: Chapter in Book/Report/Conference proceedingChapterpeer-review


Traditional cyclophotocoagulation has typically been reserved for patients with poor vision and end-stage glaucoma, but the use of a safer micropulse technique has allowed the expansion of this treatment option to patients with moderate and/or severe glaucoma. The procedure works by decreasing aqueous production either through ciliary body ablation or through increasing uveoscleral outflow with an 810 nm laser, but does not involve incisions, thus essentially eliminating the risk of bleeding or infection. Micropulse CPC is applicable also to patients with contraindications to incisional glaucoma surgery which may include elderly patients, patients who are at an increased risk of fall, and patients who are unable to make frequent postoperative visits.

Original languageEnglish
Title of host publicationOperative Dictations in Ophthalmology
Subtitle of host publicationSecond Edition
PublisherSpringer International Publishing
Number of pages3
ISBN (Electronic)9783030530587
ISBN (Print)9783030530570
StatePublished - 11 Apr 2021


  • Glaucoma
  • Laser
  • Micropulse
  • Transscleral cyclophotocoagulation (CPC)
  • Transscleral diode laser CPC


Dive into the research topics of 'Micropulse Transscleral Cyclophotocoagulation (mTSCPC)'. Together they form a unique fingerprint.

Cite this